GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Other Long Term Assets

Porton Pharma Solutions (SZSE:300363) Other Long Term Assets : ¥972 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions Other Long Term Assets?

Porton Pharma Solutions's other long-term assets for the quarter that ended in Mar. 2024 was ¥972 Mil.

Porton Pharma Solutions's quarterly other long-term assets declined from Sep. 2023 (¥980 Mil) to Dec. 2023 (¥951 Mil) but then increased from Dec. 2023 (¥951 Mil) to Mar. 2024 (¥972 Mil).

Porton Pharma Solutions's annual other long-term assets increased from Dec. 2021 (¥623 Mil) to Dec. 2022 (¥703 Mil) and increased from Dec. 2022 (¥703 Mil) to Dec. 2023 (¥951 Mil).

Porton Pharma Solutions Other Long Term Assets Historical Data

The historical data trend for Porton Pharma Solutions's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Porton Pharma Solutions Other Long Term Assets Chart

Porton Pharma Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 387.63 431.54 623.38 703.43 951.21

Porton Pharma Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 713.66 859.36 980.25 951.21 971.92

Porton Pharma Solutions Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Porton Pharma Solutions (SZSE:300363) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » Other Long Term Assets
Comparable Companies
SZSE:002773 SZSE:301015 SZSE:002399 SHSE:600422 SZSE:002317 SZSE:002675 SHSE:688192 SZSE:300199 SHSE:600062 SZSE:002737 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Website
http://www.porton.cn
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines